ArticleJournal of experimental & clinical cancer research : CR2022

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.

Antonio Cigliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.